SCHEMBL7518145

SCHEMBL7518145

COC(Cc1ccc(OCn2c3ncccc3c3cccnc32)cc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 17/20 0.53
PPARG P37231 15/20 0.53
PPARD Q03181 11/20 0.53
PTGDR2 Q9Y5Y4 1/20 0.46
PTPN1 P18031 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6752341 0.89 PPARA (0.60) PPARAPPARGPPARD
SCHEMBL6748817 0.89 PPARG (0.57) PPARAPPARGPPARDPTGDR2
SCHEMBL6752656 0.88 PPARG (0.58) PPARAPPARGPPARDPTGDR2
SCHEMBL6752358 0.87 PPARA (0.53) PPARAPPARGPPARD
SCHEMBL6752520 0.86 PPARA (0.51) PPARAPPARGPPARDPTPN1
SCHEMBL6748845 0.84 PPARA (0.53) PPARAPPARGPPARD
SCHEMBL6754497 0.84 PPARG (0.47) PPARAPPARGPPARDPTGDR2
SCHEMBL6752330 0.78 PPARA (0.72) PPARAPPARGPPARD
SCHEMBL6754496 0.78 PPARA (0.62) PPARAPPARGPPARD
SCHEMBL6752674 0.78 PPARA (0.65) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020065268-A1 New compounds, their preparation and use JEPPESEN LONE (DK) 2002-05-30 US claimed
EP-1123297-A1 NEW COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 2001-08-16 EP claimed
WO-2000023451-A1 NEW COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 2000-04-27 WO claimed
US-20020065267-A1 Compounds, their preparation and use JEPPESEN LONE (DK) 2002-05-30 US disclosed
US-20020061880-A1 New compounds, their preparation and use JEPPESEN LONE (DK) 2002-05-23 US disclosed
US-20020061876-A1 Compounds, their preparation and use JEPPESEN LONE (DK) 2002-05-23 US disclosed
EP-1179435-A1 Reversible thermochromic composition having improved light-fastness and product comprising same The Pilot Ink Co., Ltd. (JP) 2002-02-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020061880-A1 New compounds, their preparation and use PPARG, PPARD, PPARA PPARA 3/4885PPARG 1/4885PPARD 2/4885
US-20020065267-A1 Compounds, their preparation and use PPARG, PPARA, PPARD PPARA 2/4885PPARG 1/4885PPARD 3/4885
US-20020061876-A1 Compounds, their preparation and use PPARG, PPARA, PPARD PPARA 2/4885PPARG 1/4885PPARD 3/4885
US-20020065268-A1 New compounds, their preparation and use PPARG, PPARD, PPARA PPARA 3/4885PPARG 1/4885PPARD 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.